The Therapeutic Goods Association have warned that a shortage of popular hormone therapy Primoteston is anticipated to affect users over the coming months. The injectable testosterone is the most common of medical transition used by many transgender and non-binary people assigned female at birth. The Therapeutic Goods Association and LGBTI health organisation ACON are advising […]
The federal Health Department has no capacity to seek out a replacement hormone treatment for transgender men after popular drug Primoteston was removed from the Pharmaceutical Benefits Scheme. The Department of Health, through the Pharmaceutical Benefits Scheme (PBS), previously announced that from February 1st they will no longer subsidise Primoteston, the most common form of medical transition […]
The Department of Health, through the Pharmaceutical Benefits Scheme (PBS), has announced that from February 1st they will no longer subsidise Primoteston Depot, the most common form of medical transition available for transgender men and non-binary people assigned female at birth. “Primoteston Depot (testosterone enantate 250 mg injection) will be deleted from the Pharmaceutical Benefits […]
